Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Glutamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced electrodialysis technology for high-purity glutamine dipeptide production. Reduces waste and improves yield for pharmaceutical manufacturing supply chains.
Patent CN103242215A details a safer transfer hydrogenation route for Lenalidomide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Patent CN112479853A reveals a novel resin-catalyzed route for high-purity D-2-chloropropionyl chloride, offering significant cost reduction in API manufacturing and scalable production.
Patent CN110885357B details nanofiltration purification for glutamine dipeptide ensuring high purity and reduced energy consumption for reliable supply chains.
Patent CN110643670A details a high-yield chemoenzymatic route for D-glutamine production, offering significant cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Patent CN107417516A enables recycling still bottoms for D-2-chloropropionyl chloride. Enhances yield and supply continuity for pharmaceutical intermediate manufacturing partners.